Literature DB >> 15193401

Pluronic F127-based systemic vaccine delivery systems.

Claire M Coeshott1, S Louise Smithson, Evie Verderber, Adrian Samaniego, Joan M Blonder, Gary J Rosenthal, M A Julie Westerink.   

Abstract

We have developed a vaccine delivery system based on the non-ionic block copolymer, Pluronic F127 (F127), combined with selected immunomodulators. F127-based matrices are characterized by a phenomenon known as reverse thermogelation, whereby the formulation undergoes a phase transition from liquid to gel upon reaching physiological temperatures. Protein antigens (tetanus toxoid (TT), diphtheria toxoid (DT) and anthrax recombinant protective antigen (rPA)) were formulated with F127 in combination with CpG motifs or chitosan, as examples of immunomodulators, and were compared to more traditional adjuvants in mice. IgG antibody responses were significantly enhanced by the F127/CpG and F127/chitosan combinations compared to antigens mixed with CpGs or chitosan alone. In addition, the responses were significantly greater than those elicited by aluminum salts. Furthermore, the functional activity of these antibodies was demonstrated using either in vivo tetanus toxin challenge or an anthrax lethal toxin neutralization assay. These studies suggest that a block-copolymer approach could enhance the delivery of a variety of clinically useful antigens in vaccination schemes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193401     DOI: 10.1016/j.vaccine.2003.11.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

Review 2.  HPV Vaccines: today and in the Future.

Authors:  Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

3.  The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.

Authors:  Zagit Z Gaymalov; Zhihui Yang; Vladimir M Pisarev; Valery Yu Alakhov; Alexander V Kabanov
Journal:  Biomaterials       Date:  2008-12-07       Impact factor: 12.479

Review 4.  Anthrax vaccination strategies.

Authors:  Robert J Cybulski; Patrick Sanz; Alison D O'Brien
Journal:  Mol Aspects Med       Date:  2009-09-01

Review 5.  Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review.

Authors:  Mohammad Ariful Islam; Jannatul Firdous; Yun-Jaie Choi; Cheol-Heui Yun; Chong-Su Cho
Journal:  Int J Nanomedicine       Date:  2012-12-13

6.  Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.

Authors:  Bret D Ulery; Latrisha K Petersen; Yashdeep Phanse; Chang Sun Kong; Scott R Broderick; Devender Kumar; Amanda E Ramer-Tait; Brenda Carrillo-Conde; Krishna Rajan; Michael J Wannemuehler; Bryan H Bellaire; Dennis W Metzger; Balaji Narasimhan
Journal:  Sci Rep       Date:  2011-12-16       Impact factor: 4.379

7.  Rabies virus glycoprotein as a carrier for anthrax protective antigen.

Authors:  Mary Ellen Smith; Martin Koser; Sa Xiao; Catherine Siler; James P McGettigan; Catherine Calkins; Roger J Pomerantz; Bernhard Dietzschold; Matthias J Schnell
Journal:  Virology       Date:  2006-07-03       Impact factor: 3.616

8.  Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol.

Authors:  Cristiano Farace; Paola Sánchez-Moreno; Marco Orecchioni; Roberto Manetti; Francesco Sgarrella; Yolande Asara; José M Peula-García; Juan A Marchal; Roberto Madeddu; Lucia G Delogu
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

Review 9.  Immunopotentiating and Delivery Systems for HCV Vaccines.

Authors:  Alexander K Andrianov; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

10.  Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.

Authors:  Jessica A White; Jeremy S Blum; Nancy A Hosken; Joshua O Marshak; Lauren Duncan; Changcheng Zhu; Elizabeth B Norton; John D Clements; David M Koelle; Dexiang Chen; William C Weldon; M Steven Oberste; Manjari Lal
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.